Beauchesne P - Search Results

1

Fotemustine: a third-generation nitrosourea for the treatment of recurrent malignant gliomas.

Beauchesne P. Beauchesne P. Cancers (Basel). 2012 Feb 1;4(1):77-87. doi: 10.3390/cancers4010077. Cancers (Basel). 2012. PMID: 24213227 Free PMC article.

2

Extra-neural metastases of malignant gliomas: myth or reality?

Beauchesne P. Beauchesne P. Cancers (Basel). 2011 Jan 27;3(1):461-77. doi: 10.3390/cancers3010461. Cancers (Basel). 2011. PMID: 24212625 Free PMC article.

3

Three-times daily ultrafractionated radiation therapy, a novel and promising regimen for glioblastoma patients.

Beauchesne P. Beauchesne P. Cancers (Basel). 2013 Sep 25;5(4):1199-211. doi: 10.3390/cancers5041199. Cancers (Basel). 2013. PMID: 24202441 Free PMC article.

4

Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.

Beauchesne PD, Taillandier L, Bernier V, Carnin C. Beauchesne PD, et al. Cancer Chemother Pharmacol. 2009 Jun;64(1):171-5. doi: 10.1007/s00280-009-0993-x. Epub 2009 Apr 8. Cancer Chemother Pharmacol. 2009. PMID: 19352662 Clinical Trial.

5

Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis.

Bihan C, Foscolo S, Boone M, Blonski M, Coutte A, Darlix A, Beauchesne P, Lefranc M, Lorgis V, Taillandier L, Chauffert B. Bihan C, et al. Among authors: beauchesne p. Case Rep Oncol. 2012 Sep;5(3):530-6. doi: 10.1159/000343139. Epub 2012 Sep 29. Case Rep Oncol. 2012. PMID: 23139667 Free PMC article.

6

Phase II study of a radiotherapy/etoposide combination for patients with newly malignant gliomas.

Beauchesne P, Soler C, Rusch P, Fotso MJ, Duthel R, Schmitt T, Brunon J. Beauchesne P, et al. Cancer Chemother Pharmacol. 1999;44(3):210-6. doi: 10.1007/s002800050969. Cancer Chemother Pharmacol. 1999. PMID: 10453722 Clinical Trial.

7

Response to intrathecal infusions of Depocyt® in secondary diffuse leptomeningeal gliomatosis. A case report.

Beauchesne P, Blonski M, Brissart H. Beauchesne P, et al. In Vivo. 2011 Nov-Dec;25(6):991-3. In Vivo. 2011. PMID: 22021694

8

Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours.

Beauchesne P. Beauchesne P. Lancet Oncol. 2010 Sep;11(9):871-9. doi: 10.1016/S1470-2045(10)70034-6. Epub 2010 Jul 2. Lancet Oncol. 2010. PMID: 20598636 Review.

9

Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients.

Blonski M, Pallud J, Gozé C, Mandonnet E, Rigau V, Bauchet L, Fabbro M, Beauchesne P, Baron MH, Fontaine D, Peruzzi P, Darlix A, Duffau H, Taillandier L. Blonski M, et al. Among authors: beauchesne p. J Neurooncol. 2013 Jun;113(2):267-75. doi: 10.1007/s11060-013-1106-6. Epub 2013 Mar 12. J Neurooncol. 2013. PMID: 23479036

10

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.

Brandes AA, Gil-Gil M, Saran F, Carpentier AF, Nowak AK, Mason W, Zagonel V, Dubois F, Finocchiaro G, Fountzilas G, Cernea DM, Chinot O, Anghel R, Ghiringhelli F, Beauchesne P, Lombardi G, Franceschi E, Makrutzki M, Mpofu C, Urban HJ, Pichler J. Brandes AA, et al. Among authors: beauchesne p. Oncologist. 2019 Apr;24(4):521-528. doi: 10.1634/theoncologist.2018-0290. Epub 2018 Sep 28. Oncologist. 2019. PMID: 30266892 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page